ArticleMolecular genetics and metabolism2020
The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective.
Article in Molecular genetics and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Artificial Intelligence, Connected Care, and Enabling Digital Health Technologies in Rare Diseases With a Focus on Lysosomal Storage Disorders: Scoping Review.Journal of medical Internet research · 2026Article
- Impact of COVID-19 infection in patients with inherited metabolic diseases: a National Multicenter Study from the French IMDs Healthcare Network for Rare Diseases.Orphanet journal of rare diseases · 2026Article
- Healthcare access satisfaction before and during the COVID-19 pandemic among Peruvian children with down syndrome.BMC pediatrics · 2025Article
- Impact of COVID-19 on growth hormone therapy efficacy in pediatric patients with short stature.Endocrine connections · 2025Article
- Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey.Orphanet journal of rare diseases · 2023Article
- Recent Advances in Phenylketonuria: A Review.Cureus · 2023Review
- Newborn Screening in a Pandemic-Lessons Learned.International journal of neonatal screening · 2023Review
- COVID-19 Vaccine in Inherited Metabolic Disorders Patients: A Cross-Sectional Study on Rate of Acceptance, Safety Profile and Effect on Disease.International journal of environmental research and public health · 2022Article
- Impact of COVID-19 on Pediatric Laboratory Medicine: An IFCC C-ETPLM, SSIEM, ISNS Global Survey.EJIFCC · 2022Review
- Impact of the COVID-19 pandemic on medical genetics and genomics training: Perspective from clinical trainees.American journal of medical genetics. Part A · 2022Article
- Inborn error of metabolism precipitated by COVID-19: challenges in the absence of an expanded newborn screening as state health programmes.BMJ case reports · 2022Article
- Unmet Needs of Children with Inherited Metabolic Disorders in the COVID-19 Pandemic.Turkish archives of pediatrics · 2022Article
- Global impact of COVID-19 on newborn screening programmes.BMJ global health · 2022Article
- Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatment.Orphanet journal of rare diseases · 2022Article
- COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases-Organizational Challenges from the Point of View of Healthcare Providers.Journal of clinical medicine · 2021Article
- Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia.Healthcare (Basel, Switzerland) · 2021Article
- COVID-19 and Inherited Metabolic Disorders: One-Year Experience of a Referral Center.Children (Basel, Switzerland) · 2021Article
- A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria.Orphanet journal of rare diseases · 2021Article
- Provider Perspectives on the Impact of the COVID-19 Pandemic on Newborn Screening.International journal of neonatal screening · 2021Article
- Hospital care of patients with inherited cardiomyopathies in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network.American journal of medical genetics. Part A · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantitative estimates for the global impact of COVID-19 on the diagnosis and management of patients with inborn errors of metabolism (IEM) are lacking. We collected relevant data from 16 specialized medical centers treating IEM patients in Europe, Asia and Africa. The median decline of reported IEM related services in March 1st-May 31st 2020 compared to the same period in 2019 were as high as 60-80% with a profound impact on patient management and care for this vulnerable patient group. More representative data along with outcome data and guidelines for managing IEM disorders under such extraordinary circumstances are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.